Silver Book Fact

U.S. spending on cancer treatment has risen greatly over time, from $13.1 billion in 1980 to $72.1 billion in 2004. 

Phillipson, Thomas, Michael Eber, Darius N. Lakdawalla, Mitra Corral, Rena Conti, and Dana P. Goldman. An Analysis Of Whether Higher Health Care Spending In The United States Versus Europe Is ‘Worth It’ In The Case of Cancer. Health Affairs. 2012; 31(4): 667-675

Reference

Title
An Analysis Of Whether Higher Health Care Spending In The United States Versus Europe Is ‘Worth It’ In The Case of Cancer
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2012
Authors
Phillipson, Thomas, Michael Eber, Darius N. Lakdawalla, Mitra Corral, Rena Conti, and Dana P. Goldman
Volume & Issue
Volume 31, Issue 4
Pages
667-675

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • The top two leading causes of death among those over 65 years of age, regardless of race, sex, or Hispanic origin are heart disease and cancer  
  • Patients’ treatment times differed during their last year of life, because of increased hospitalization. Treatment times were longest for gastric, lung and ovarian cancers — 35.4, 32.4, and 31.9 days,…  
  • Cancer accounts for a quarter of all deaths in the U.S.  
  • Close to 77% of all cancers are diagnosed in Americans age 55 years and older.  
  • Cancer Incidence and Mortality Rates by Site, Race, and Ethnicity, US, 2000-2004